4-(BENZYLOXY)CYCLOHEXANECARBOXYLIC ACID, 95.0%, 250mg

Hydroxypropyl Acrylate (mixture of 2-Hydroxypropyl and 2-Hydroxy-1-methylethyl Acrylate) (stabilized with MEHQ)>90.0%(GC)25mL

2-Chlorophenylhydrazine hydrochloride, 97.0%, 1g

4-Bromopyridine hydrochloride, 98.0%, 10g

3-nitro-1H,5H-pyrazolo[1,5-a]pyrimidin-5-one, 97%, 1g

Methyl 4-(((2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)-2-methoxybenzoate, 97.0%, 1g

2'-Nitro-[1,1'-biphenyl]-2-carboxylic acid, 95%, 100mg

3-(Cyclopropylmethoxy)piperidine, 95%, 250mg

2,1,3-Benzoselenadiazole>98.0%(GC)200mg

ethyl 3-{[3-(diethylamino)propyl]amino}propanoate, 95.0%, 2g

(4aR,7aR)-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate, 97%, 100mg

9-Bromoanthracene, 97.0%, 100g

N-(3-(1H-imidazol-1-yl)propyl)-7-chloro-4-methoxybenzo[d]thiazol-2-amine, 95.0%, 500mg